BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10728492)

  • 1. Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat.
    Cleton A; de Greef HJ; Edelbroek PM; Voskuyl RA; Danhof M
    J Pharmacokinet Biopharm; 1999 Jun; 27(3):301-23. PubMed ID: 10728492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Br J Pharmacol; 2000 Jul; 130(5):1037-44. PubMed ID: 10882388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat.
    Cleton A; de Greef HJ; Edelbroek PM; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 Dec; 128(8):1651-8. PubMed ID: 10588919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of γ-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and γ-Aminobutyric acid metabolism in the anesthetized rat In vivo.
    Patel AB; de Graaf RA; Rothman DL; Behar KL
    J Neurosci Res; 2015 Jul; 93(7):1101-8. PubMed ID: 25663257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat.
    Lancel M; Faulhaber J; Deisz RA
    Br J Pharmacol; 1998 Apr; 123(7):1471-7. PubMed ID: 9579745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.
    Cox EH; Van Hemert JG; Tukker EJ; Danhof M
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):99-108. PubMed ID: 9403781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats.
    Coenen AM; Blezer EH; van Luijtelaar EL
    Epilepsy Res; 1995 Jun; 21(2):89-94. PubMed ID: 7588592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Parvez NS; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis.
    Ipponi A; Lamberti C; Medica A; Bartolini A; Malmberg-Aiello P
    Eur J Pharmacol; 1999 Mar; 368(2-3):205-11. PubMed ID: 10193656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolateral thalamus.
    Richards DA; Bowery NG
    Neurochem Res; 1996 Feb; 21(2):135-40. PubMed ID: 9182238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
    Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C
    Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition.
    Schmitt U; Lüddens H; Hiemke C
    Pharmacol Biochem Behav; 2000 Feb; 65(2):351-6. PubMed ID: 10672990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tiagabine, a gamma-aminobutyric acid re-uptake inhibitor, on normal rat bladder function.
    Pehrson R; Andersson KE
    J Urol; 2002 May; 167(5):2241-6. PubMed ID: 11956486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of the GABA uptake blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neurones.
    Roepstorff A; Lambert JD
    Neurosci Lett; 1992 Nov; 146(2):131-4. PubMed ID: 1337191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined administration of ethanol and tiagabine on rabbit EEG.
    Pietrzak B; Czarnecka E
    Pharmacol Rep; 2006; 58(6):890-9. PubMed ID: 17220547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the GABA-uptake inhibitor tiagabine in rat globus pallidus.
    Chen L; Yung WH
    Exp Brain Res; 2003 Sep; 152(2):263-9. PubMed ID: 12879169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.